CDI Labs Canada Inc., a provider of services for proteome-wide antibody profiling and target identification, announced the launch of its Technology Access Program for custom peptide libraries for serum antibody analysis services. These services utilize phage display immunoprecipitation sequencing (PhIP-Seq), a powerful method of multiplexed analysis that combines next-generation proteomics with high-throughput DNA sequencing, to provide researchers with unparalleled insights into the intricate connection between antibodies and diseases. This new capability allows scientists to conduct epitope-level antibody discovery and profiling using a peptide library designed for their specific research needs.
"CDI Labs is dedicated to offering researchers cutting-edge and highly flexible services to unlock the crucial insights hidden in serum antibodies, paving the way for a deeper understanding of human diseases and conditions," said Barney Saunders, PhD, CEO of CDI Labs. "Our customized PhIP-Seq libraries address the growing need for tailored solutions in the rapidly advancing field of high-throughput serology. Researchers can now conduct epitope-level antibody discovery and profiling with libraries specifically designed for their unique requirements, enhancing efficiency and expanding the technology's accessibility and relevance to a broader scientific community."